Validity of the Montreal Cognitive Assessment (MoCA) as a Screening Test for Mild Cognitive Impairment (MCI) in a Cardiovascular Population

While rates of mild cognitive impairment (MCI) are relatively high in populations with cardiovascular diseases and risk factors, screening tests for MCI have not been evaluated in this patient group. This study investigated the sensitivity and specificity of the Montreal Cognitive Assessment (MoCA)...

Full description

Saved in:
Bibliographic Details
Published in:Journal of geriatric psychiatry and neurology 2011-03, Vol.24 (1), p.33-38
Main Authors: McLennan, S.N., Mathias, J.L., Brennan, L.C., Stewart, S.
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Biological and medical sciences
Cardiovascular Diseases - complications
Cognition Disorders - complications
Cognition Disorders - diagnosis
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Female
Fundamental and applied biological sciences. Psychology
Geriatrics
Humans
Male
Mass Screening
Medical sciences
Mental Status Schedule
Middle Aged
Neurology
Neuropsychological Tests
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Reproducibility of Results
Sensitivity and Specificity
Vertebrates: nervous system and sense organs
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c464t-4e44b75cc638552b9e1591d1884f83d52ba79f52a3dac9e4cc1b622f9f918fbd3
cites cdi_FETCH-LOGICAL-c464t-4e44b75cc638552b9e1591d1884f83d52ba79f52a3dac9e4cc1b622f9f918fbd3
container_end_page 38
container_issue 1
container_start_page 33
container_title Journal of geriatric psychiatry and neurology
container_volume 24
creator McLennan, S.N.
Mathias, J.L.
Brennan, L.C.
Stewart, S.
description While rates of mild cognitive impairment (MCI) are relatively high in populations with cardiovascular diseases and risk factors, screening tests for MCI have not been evaluated in this patient group. This study investigated the sensitivity and specificity of the Montreal Cognitive Assessment (MoCA) tool for detecting MCI in 110 patients (mean age 67.9 + 11.7 years; 60% female) recruited from hospital cardiovascular outpatient clinics. Mean MoCA performance was relatively low (22.8 + 3.8) in this group, with 72.1% of participants scoring below the recommended cutoff for cognitive impairment (
doi_str_mv 10.1177/0891988710390813
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_954618633</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0891988710390813</sage_id><sourcerecordid>954618633</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-4e44b75cc638552b9e1591d1884f83d52ba79f52a3dac9e4cc1b622f9f918fbd3</originalsourceid><addsrcrecordid>eNqFkUFv1DAQha0K1G4L956QLwh6SPHEdmIfVxGUlboqEoVr5Dj21lViL3ZSqb-hfxqvdqEICXEayfO9N-N5CJ0DuQSo6w9ESJBC1ECoJALoEVoA52XBayJeoMWuXez6J-g0pXtCCJeCHqOTEoBXUsgFevquBte76REHi6c7g9fBT9GoATdh493kHgxepmRSGo2f8Pt1aJYXWCWs8FcdjfHOb_CtSRO2IeK1G_o_hKtxq1w8CJvVBXY-6xoVexceVNLzoCL-Era5Ti74V-ilVUMyrw_1DH379PG2-Vxc31ytmuV1oVnFpoIZxrqaa11RkT_bSQNcQg9CMCton19ULS0vFe2VloZpDV1VllZaCcJ2PT1D7_a-2xh-zHn3dnRJm2FQ3oQ5tZKzCkRF6X9JwUHSKk_PJNmTOoaUorHtNrpRxccWSLvLqv07qyx5czCfu9H0vwW_wsnA2wOQb6UGG5XXLj1zVNaUkZ1RseeS2pj2PszR5_P9e_BPpYSofw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>851936591</pqid></control><display><type>article</type><title>Validity of the Montreal Cognitive Assessment (MoCA) as a Screening Test for Mild Cognitive Impairment (MCI) in a Cardiovascular Population</title><source>SAGE</source><creator>McLennan, S.N. ; Mathias, J.L. ; Brennan, L.C. ; Stewart, S.</creator><creatorcontrib>McLennan, S.N. ; Mathias, J.L. ; Brennan, L.C. ; Stewart, S.</creatorcontrib><description>While rates of mild cognitive impairment (MCI) are relatively high in populations with cardiovascular diseases and risk factors, screening tests for MCI have not been evaluated in this patient group. This study investigated the sensitivity and specificity of the Montreal Cognitive Assessment (MoCA) tool for detecting MCI in 110 patients (mean age 67.9 + 11.7 years; 60% female) recruited from hospital cardiovascular outpatient clinics. Mean MoCA performance was relatively low (22.8 + 3.8) in this group, with 72.1% of participants scoring below the recommended cutoff for cognitive impairment (&lt;26). The presence of MCI was determined using the Neuropsychological Assessment Battery Screening Module (NAB-SM). Both amnestic MCI and multiple-domain MCI were identified. The optimum MoCA cutoff for detecting MCI in this group was &lt;24. At this cutoff, the MoCA’s sensitivity for detecting amnestic MCI was 100% and for multiple-domain MCI it was 83.3%. Specificity rates for amnestic MCI and multiple-domain MCI were 50.0% and 52% respectively. The poor specificity of the MoCA suggests that it will have limited value as a screening test for MCI in settings where the overall prevalence of MCI is low.</description><identifier>ISSN: 0891-9887</identifier><identifier>EISSN: 1552-5708</identifier><identifier>DOI: 10.1177/0891988710390813</identifier><identifier>PMID: 21156989</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Aged ; Aged, 80 and over ; Biological and medical sciences ; Cardiovascular Diseases - complications ; Cognition Disorders - complications ; Cognition Disorders - diagnosis ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Female ; Fundamental and applied biological sciences. Psychology ; Geriatrics ; Humans ; Male ; Mass Screening ; Medical sciences ; Mental Status Schedule ; Middle Aged ; Neurology ; Neuropsychological Tests ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Reproducibility of Results ; Sensitivity and Specificity ; Vertebrates: nervous system and sense organs</subject><ispartof>Journal of geriatric psychiatry and neurology, 2011-03, Vol.24 (1), p.33-38</ispartof><rights>The Author(s) 2011</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-4e44b75cc638552b9e1591d1884f83d52ba79f52a3dac9e4cc1b622f9f918fbd3</citedby><cites>FETCH-LOGICAL-c464t-4e44b75cc638552b9e1591d1884f83d52ba79f52a3dac9e4cc1b622f9f918fbd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23973403$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21156989$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McLennan, S.N.</creatorcontrib><creatorcontrib>Mathias, J.L.</creatorcontrib><creatorcontrib>Brennan, L.C.</creatorcontrib><creatorcontrib>Stewart, S.</creatorcontrib><title>Validity of the Montreal Cognitive Assessment (MoCA) as a Screening Test for Mild Cognitive Impairment (MCI) in a Cardiovascular Population</title><title>Journal of geriatric psychiatry and neurology</title><addtitle>J Geriatr Psychiatry Neurol</addtitle><description>While rates of mild cognitive impairment (MCI) are relatively high in populations with cardiovascular diseases and risk factors, screening tests for MCI have not been evaluated in this patient group. This study investigated the sensitivity and specificity of the Montreal Cognitive Assessment (MoCA) tool for detecting MCI in 110 patients (mean age 67.9 + 11.7 years; 60% female) recruited from hospital cardiovascular outpatient clinics. Mean MoCA performance was relatively low (22.8 + 3.8) in this group, with 72.1% of participants scoring below the recommended cutoff for cognitive impairment (&lt;26). The presence of MCI was determined using the Neuropsychological Assessment Battery Screening Module (NAB-SM). Both amnestic MCI and multiple-domain MCI were identified. The optimum MoCA cutoff for detecting MCI in this group was &lt;24. At this cutoff, the MoCA’s sensitivity for detecting amnestic MCI was 100% and for multiple-domain MCI it was 83.3%. Specificity rates for amnestic MCI and multiple-domain MCI were 50.0% and 52% respectively. The poor specificity of the MoCA suggests that it will have limited value as a screening test for MCI in settings where the overall prevalence of MCI is low.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular Diseases - complications</subject><subject>Cognition Disorders - complications</subject><subject>Cognition Disorders - diagnosis</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Geriatrics</subject><subject>Humans</subject><subject>Male</subject><subject>Mass Screening</subject><subject>Medical sciences</subject><subject>Mental Status Schedule</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Neuropsychological Tests</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Reproducibility of Results</subject><subject>Sensitivity and Specificity</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0891-9887</issn><issn>1552-5708</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkUFv1DAQha0K1G4L956QLwh6SPHEdmIfVxGUlboqEoVr5Dj21lViL3ZSqb-hfxqvdqEICXEayfO9N-N5CJ0DuQSo6w9ESJBC1ECoJALoEVoA52XBayJeoMWuXez6J-g0pXtCCJeCHqOTEoBXUsgFevquBte76REHi6c7g9fBT9GoATdh493kHgxepmRSGo2f8Pt1aJYXWCWs8FcdjfHOb_CtSRO2IeK1G_o_hKtxq1w8CJvVBXY-6xoVexceVNLzoCL-Era5Ti74V-ilVUMyrw_1DH379PG2-Vxc31ytmuV1oVnFpoIZxrqaa11RkT_bSQNcQg9CMCton19ULS0vFe2VloZpDV1VllZaCcJ2PT1D7_a-2xh-zHn3dnRJm2FQ3oQ5tZKzCkRF6X9JwUHSKk_PJNmTOoaUorHtNrpRxccWSLvLqv07qyx5czCfu9H0vwW_wsnA2wOQb6UGG5XXLj1zVNaUkZ1RseeS2pj2PszR5_P9e_BPpYSofw</recordid><startdate>20110301</startdate><enddate>20110301</enddate><creator>McLennan, S.N.</creator><creator>Mathias, J.L.</creator><creator>Brennan, L.C.</creator><creator>Stewart, S.</creator><general>SAGE Publications</general><general>Sage Publications</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20110301</creationdate><title>Validity of the Montreal Cognitive Assessment (MoCA) as a Screening Test for Mild Cognitive Impairment (MCI) in a Cardiovascular Population</title><author>McLennan, S.N. ; Mathias, J.L. ; Brennan, L.C. ; Stewart, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-4e44b75cc638552b9e1591d1884f83d52ba79f52a3dac9e4cc1b622f9f918fbd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular Diseases - complications</topic><topic>Cognition Disorders - complications</topic><topic>Cognition Disorders - diagnosis</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Geriatrics</topic><topic>Humans</topic><topic>Male</topic><topic>Mass Screening</topic><topic>Medical sciences</topic><topic>Mental Status Schedule</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Neuropsychological Tests</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Reproducibility of Results</topic><topic>Sensitivity and Specificity</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McLennan, S.N.</creatorcontrib><creatorcontrib>Mathias, J.L.</creatorcontrib><creatorcontrib>Brennan, L.C.</creatorcontrib><creatorcontrib>Stewart, S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>Journal of geriatric psychiatry and neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McLennan, S.N.</au><au>Mathias, J.L.</au><au>Brennan, L.C.</au><au>Stewart, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validity of the Montreal Cognitive Assessment (MoCA) as a Screening Test for Mild Cognitive Impairment (MCI) in a Cardiovascular Population</atitle><jtitle>Journal of geriatric psychiatry and neurology</jtitle><addtitle>J Geriatr Psychiatry Neurol</addtitle><date>2011-03-01</date><risdate>2011</risdate><volume>24</volume><issue>1</issue><spage>33</spage><epage>38</epage><pages>33-38</pages><issn>0891-9887</issn><eissn>1552-5708</eissn><abstract>While rates of mild cognitive impairment (MCI) are relatively high in populations with cardiovascular diseases and risk factors, screening tests for MCI have not been evaluated in this patient group. This study investigated the sensitivity and specificity of the Montreal Cognitive Assessment (MoCA) tool for detecting MCI in 110 patients (mean age 67.9 + 11.7 years; 60% female) recruited from hospital cardiovascular outpatient clinics. Mean MoCA performance was relatively low (22.8 + 3.8) in this group, with 72.1% of participants scoring below the recommended cutoff for cognitive impairment (&lt;26). The presence of MCI was determined using the Neuropsychological Assessment Battery Screening Module (NAB-SM). Both amnestic MCI and multiple-domain MCI were identified. The optimum MoCA cutoff for detecting MCI in this group was &lt;24. At this cutoff, the MoCA’s sensitivity for detecting amnestic MCI was 100% and for multiple-domain MCI it was 83.3%. Specificity rates for amnestic MCI and multiple-domain MCI were 50.0% and 52% respectively. The poor specificity of the MoCA suggests that it will have limited value as a screening test for MCI in settings where the overall prevalence of MCI is low.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>21156989</pmid><doi>10.1177/0891988710390813</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0891-9887
ispartof Journal of geriatric psychiatry and neurology, 2011-03, Vol.24 (1), p.33-38
issn 0891-9887
1552-5708
language eng
recordid cdi_proquest_miscellaneous_954618633
source SAGE
subjects Aged
Aged, 80 and over
Biological and medical sciences
Cardiovascular Diseases - complications
Cognition Disorders - complications
Cognition Disorders - diagnosis
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Female
Fundamental and applied biological sciences. Psychology
Geriatrics
Humans
Male
Mass Screening
Medical sciences
Mental Status Schedule
Middle Aged
Neurology
Neuropsychological Tests
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Reproducibility of Results
Sensitivity and Specificity
Vertebrates: nervous system and sense organs
title Validity of the Montreal Cognitive Assessment (MoCA) as a Screening Test for Mild Cognitive Impairment (MCI) in a Cardiovascular Population
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T07%3A19%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validity%20of%20the%20Montreal%20Cognitive%20Assessment%20(MoCA)%20as%20a%20Screening%20Test%20for%20Mild%20Cognitive%20Impairment%20(MCI)%20in%20a%20Cardiovascular%20Population&rft.jtitle=Journal%20of%20geriatric%20psychiatry%20and%20neurology&rft.au=McLennan,%20S.N.&rft.date=2011-03-01&rft.volume=24&rft.issue=1&rft.spage=33&rft.epage=38&rft.pages=33-38&rft.issn=0891-9887&rft.eissn=1552-5708&rft_id=info:doi/10.1177/0891988710390813&rft_dat=%3Cproquest_cross%3E954618633%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c464t-4e44b75cc638552b9e1591d1884f83d52ba79f52a3dac9e4cc1b622f9f918fbd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=851936591&rft_id=info:pmid/21156989&rft_sage_id=10.1177_0891988710390813&rfr_iscdi=true